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Background: Walking for exercise remains the most frequently reported leisure-time activity, likely because it is
simple, inexpensive, and easily incorporated into most people’s lifestyle. Pedometers are simple, convenient, and
economical tools that can be used to quantify step-determined physical activity. Few studies have attempted to
define the direct relationship between dynamic changes in pedometer-determined steps/day and changes in
anthropometric and clinical outcomes. Hence, the objective of this secondary analysis was to evaluate the utility
of several descriptive indicators of pedometer-determined steps/day for predicting changes in anthropometric
and clinical outcomes using data from a community-based walking intervention, HUB City Steps, conducted in
a southern, African American population. A secondary aim was to evaluate whether treating steps/day data
for implausible values affected the ability of these data to predict intervention-induced changes in clinical and
anthropometric outcomes.
Methods: The data used in this secondary analysis were collected in 2010 from 269 participants in a six-month
walking intervention targeting a reduction in blood pressure. Throughout the intervention, participants submitted
weekly steps/day diaries based on pedometer self-monitoring. Changes (six-month minus baseline) in
anthropometric (body mass index, waist circumference, percent body fat [%BF], fat mass) and clinical (blood
pressure, lipids, glucose) outcomes were evaluated. Associations between steps/day indicators and changes in
anthropometric and clinical outcomes were assessed using bivariate tests and multivariable linear regression
analysis which controlled for demographic and baseline covariates.
Results: Significant negative bivariate associations were observed between steps/day indicators and the majority
of anthropometric and clinical outcome changes (r = -0.3 to -0.2: P < 0.05). After controlling for covariates in the
regression analysis, only the relationships between steps/day indicators and changes in anthropometric (not clinical)
outcomes remained significant. For example, a 1,000 steps/day increase in intervention mean steps/day resulted in
a 0.1% decrease in %BF. Results for the three pedometer datasets (full, truncated, and excluded) were similar and
yielded few meaningful differences in interpretation of the findings.
Conclusions: Several descriptive indicators of steps/day may be useful for predicting anthropometric outcome
changes. Further, manipulating steps/day data to address implausible values has little overall effect on the ability
to predict these anthropometric changes.
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Walking for exercise remains the most frequently
reported leisure-time activity [1], likely because it is sim-
ple, inexpensive, and easily incorporated into most peo-
ple’s lifestyle. The multiple health benefits of walking are
well established and include weight management [2],
reduced blood pressure [2-4], and improved lipid pro-
files [5] and glucose tolerance/insensitivity [6-8]. Despite
these well known benefits, 36% of adults in the United
States (US) were classified as sedentary (defined as the
accumulation of < 5,000 steps/day) in 2005–2006 [9].
The situation is even worse for African American adults
since overweight and obesity rates exceed those of the
general population [10], and they are much more likely
to take fewer steps/day and therefore be classified as
sedentary as compared to white adults [9].
Compared to accelerometers, pedometers are simple,
convenient, and inexpensive tools that can be used to
quantify step-determined physical activity. A relative
lack of steps/day is used to infer a physically inactive life-
style. Pedometers have been used to describe steps/day
taken by various populations [11-15], explore steps/day
values required to achieve health benefits [16], evaluate
intervention effectiveness [17-19], and promote healthy
lifestyles [20-24]. However, few studies have attempted to
define the direct relationship between dynamic changes in
pedometer-determined steps/day and changes in an-
thropometric and clinical outcomes. The direct connec-
tion between changes in steps/day and changes in targeted
health outcomes is lacking for all races/ethnicities, includ-
ing African Americans. Further, based on a review of 27
pedometer-based, physical activity interventions, the dif-
ference between steps/day values collected (for three to
seven days) at baseline and post-intervention was used as
a measure of change [25]. However, it is not clear that this
is the ‘best’ indicator for predicting health outcome
changes. Hence, the primary objective of this secondary
analysis was to evaluate the utility of several descriptive
indicators of pedometer-determined steps/day for predict-
ing changes in anthropometric and clinical outcomes using
data from a community-based walking intervention, HUB
City Steps, conducted in a southern African American
population. A secondary objective was to evaluate whether
treating steps/day data for implausible values affected the
ability of these data to predict intervention-induced
changes in anthropometric and clinical outcomes.Methods
Study design
The procedures followed in the HUB City Steps study were
approved by the Institutional Review Board of the Univer-
sity of Southern Mississippi, Hattiesburg, Mississippi.
Informed consent was obtained from all study participants.Although the study was designed in two phases, an initial
six months of intervention followed by 12 months of main-
tenance, only the intervention phase is relevant to these
analyses. The quasi-experimental intervention phase was
designed to assess the effectiveness of intervention treat-
ment on blood pressure (BP) as well as a variety of other
clinical (e.g. lipids, glucose) and anthropometric (e.g. body
mass index [BMI], waist circumference, percent body fat [%
BF], fat mass, lean body mass) outcomes. Recruitment of
study participants involved a variety of methods including
flyers, word of mouth, and community events. Eligibility
criteria included age (18 years or older), English speaker,
non-institutionalized, and resident in Hattiesburg area.
Individuals with BP ≥ 180/110 were disqualified from par-
ticipation and directed to seek immediate medical attention.
All other individuals were eligible for participation regard-
less of BP status and medication regimen. Briefly, the phys-
ical activity component of the intervention included
walking coaches who provided support to encourage walk-
ing, goal setting, and submission of pedometer diaries; and
monthly education sessions with group physical activity and
sharing of successes and challenges. A more detailed de-
scription of the HUB City Steps methodology can be found
elsewhere [26]. This secondary analysis is focused on data
collected at baseline (January-February 2010) and at the
six-month visit (July 2010) following the initial intervention
phase.
Measures
Questionnaire data included demographic characteris-
tics, medical diagnoses, medications, and smoking.
Anthropometric measures included height, weight,
waist circumference, %BF, fat mass, and lean mass.
Height was measured using a portable stadiometer and
a Tanita scale (model TBF-310T, standard adult mode)
was used to measure weight and %BF (based on
bioelectrical impedance analysis) [27], and to calculate
BMI. Clinical measures included systolic and diastolic
blood pressure (SBP and DBP), lipids, and glucose.
Systolic and diastolic blood pressures were assessed
using an OMRON HEM-907XL automatic inflation
sphygmomanometer, which has been used in large
scale clinical trials [28,29]. Non-fasting cholesterol,
triglycerides, and glucose were assessed using the
Cholestech LDX Lipid Analyzer, which is a reliable al-
ternative to the conventional biochemical routine [30].
As a measure of fitness, the self-paced 6-minute walk
test (6MWT) was performed. The 6MWT is reliable
and can discriminate between fitness levels in a high-
functioning population [31]. A more detailed descrip-
tion of the HUB City Steps procedures for data
collection can be found elsewhere [26].
Each participant was given a Yamax pedometer
(model SW-701, Yamax Corporation, Tokyo, Japan) with
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the entire intervention period on their waist during wak-
ing hours; to remove only upon showering, bathing or
swimming; and to reset the pedometer to zero each
morning. Participants had the option of recording their
steps/day using weekly pedometer diary postcards or the
intervention’s website. In either case, participant-recorded
steps/day were uniformly added to the database. Partici-
pants’ steps/day were not assessed prior to the initiation
of the study’s six-month intervention phase.Statistical analyses
All statistical analyses were performed using SASW soft-
ware, version 9.2 (SAS Institute Inc., Cary, NC). Three
pedometer datasets, full, truncated, and excluded, were
used to compute and compare associations between
indicators of pedometer-determined steps/day and
changes in anthropometric and clinical parameters. The
steps/day plausibility range was defined as values falling
between 500 and 30,000 steps/day inclusive [32]. Thus,
the full dataset consisted of all values, regardless of their
plausibility. In the truncated dataset, values falling above
or below the plausibility range were truncated to the
respective end points (i.e. steps/day < 500 recoded as
500; steps/day > 30,000 recoded as 30,000). In the
excluded dataset, values falling above or below the
plausibility range were excluded from analysis. All parti-
cipants who reported steps/day for at least one interven-
tion day were included in the analyses.
Several methodological approaches to computing de-
scriptive indicators of steps/day were explored and
included measures of central tendency, proportions, and
categorical variables. Additionally, these indicators were
computed over the entire intervention period (referred
to as intervention indicators) and for differences between
steps/day reported during the first two weeks of the
intervention and the remaining weeks (3–27; referred to
as change in intervention indicators). Positive changes
represent an increase in steps/day between the initial
and remaining weeks for the intervention period. Since
steps/day were not collected prior to the intervention
period, change in intervention steps/day indicators repre-
sent persistence in or maintenance of step-defined phys-
ical activity rather than a true change from a pre-
intervention baseline. Intervention indicators included
mean, median, proportion of reported days meeting
7,500 and 10,000 steps/day, and four- and six-category
step-defined physical activity classifications (based on
intervention mean steps/day). The six-category classifica-
tion consisted of: basal (< 2,500 steps/day), limited
(2,500 – 4,999), low active (5,000 – 7,499), somewhat ac-
tive (7,500 – 9,999), active (10,000 – 12,499), and highly
active (≥ 12,500) [33]. The four-category classificationcollapsed the basal and limited categories into a seden-
tary (< 5,000 steps/day) category, while the active and
highly active categories were collapsed into a single ac-
tive (≥ 10,000) category. Intervention change indicators
included change in mean, median, and the four- and six-
category step-defined physical activity classifications.
Descriptive statistics including means, standard
deviations, frequencies, and percentages were used to
summarize demographic characteristics, descriptive
indicators of steps/day, and anthropometric and clinical
outcomes. Chi square or Fisher’s exact tests (categorical
variables) and two sample t tests (continuous variables)
were used to test for significant differences between par-
ticipant subgroups, study completers and non-completers.
Study completers were defined as participants who pro-
vided both baseline and six-month follow-up measures,
while study non-completers were defined as participants
who provided only baseline measures. Pearson’s correl-
ation coefficients were used to characterize bivariate rela-
tionships between steps/day indicators and changes in
outcome variables. Multivariate linear regression models
were built to determine if significant associations between
the steps/day indicators and changes in outcome variables
remained significant after controlling for covariates. The
outcome (dependent) variables included changes in waist
circumference, BMI, %BF, fat mass, total cholesterol, tri-
glycerides, and glucose. The predictor (independent)
steps/day variables included intervention and change in
intervention mean and median steps/day, the proportion
of reported days which met at least 7,500 or 10,000 steps/
day, and changes in intervention four- and six-category
step-defined physical activity classifications. Covariates
included in the models were age, sex, marital status, edu-
cation, income, smoking status, BMI, diagnosis of respect-
ive chronic condition (high cholesterol, high glucose),
fitness (based on 6MWT), compliance with recording
steps/day (based upon proportion of completed daily step
logs), and baseline value of the respective outcome
variable. For comparison and modeling purposes,
marital status was categorized as married or not mar-
ried (including widowed, divorced, separated, and
never married); education was categorized as less than
high school, high school graduate/GED, or some college
(including trade or vocational school and any college
regardless of degree); while income was treated as a
continuous variable due to the relatively large number
(n=12) of original categories. Because our preliminary
analyses indicated that there were no confounding
effects for medication change (only eight participants
reported a change during the study), it was not
included as a covariate in these analyses. Only data
from study completers were included in the analyses
involving associations with steps/day indicators. The
significance level of the tests was set at 0.05 although
Table 1 Baseline demographic and clinical characteristics









African American 254 94.4
White 14 5.2






Never married 89 33.1
Education
Less than high school 12 4.5
High school graduate/GED 41 15.2
Trade or vocational school 13 4.8
Some college 61 22.7
College degree 76 28.3
Some graduate/professional 19 7.1








Current smoker 23 8.6
Diagnosed high blood pressure 112 41.6
Diagnosed high blood sugar 42 15.6
Diagnosed high cholesterol 52 19.3
Mean SD
Age (years) 44 12.2
Waist circumference (cm) 102 17.6
Body mass index (kg/m2) 34.7 8.13
Body fat (%) 42.4 10.20
Fat mass (kg) 42.3 18.79
Lean body mass (kg) 52.4 12.75
Systolic blood pressure (mm Hg) 126 19.2
Diastolic blood pressure (mm Hg) 83 12.3
Total cholesterol (mg/dL) 177 39.1
High density lipoprotein (mg/dL) 52 15.0
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Of the 345 individuals from the Hattiesburg, Mississippi
community who expressed interest and were screened
for the study, 269 (78%) completed the baseline assess-
ment, all of which were eligible, and were enrolled in
HUB City Steps. At six-month follow-up, 190 (71%) par-
ticipants were re-assessed. Baseline demographic and
clinical characteristics are presented in Table 1 for the
269 participants. The majority of participants were
African American (94%) and female (85%) with a mean
age of 44 years. Less than half (42%) of participants were
married, over three-fourths (79%) had some college edu-
cation, while approximately one-fourth (26%) reported a
household income greater than $50,000 per year. Very
few (9%) participants currently smoked and diagnoses of
chronic conditions ranged from 16% for high blood glu-
cose to 42% for high blood pressure. Mean BMI was
35 kg/m2 and mean SBP and DBP were 126 and 83 mm
Hg, respectively. Demographic and clinical comparisons
between study completers and non-completers revealed
no significant differences between the two groups for
sex, marital status, education, smoking status, prevalence
of self-reported chronic conditions (high blood pressure,
high blood glucose, and high cholesterol), waist circum-
ference, %BF, fat mass, lean body mass, blood pressures,
total cholesterol, high density lipoprotein (HDL), low
density lipoprotein (LDL), glucose, or 6MWT (data not
shown). However, study completers were significantly
older (46 vs. 40 years, respectively; p < 0.0001), had lower
mean BMI (34 vs. 37 kg/m2, respectively; p = 0.0150), and
had higher mean triglycerides (137 vs. 117 mg/dL,
respectively; p = 0.0389) at baseline as compared to non-
completers.
Pedometer-determined steps/day
Steps/day were reported for over half (55%) of the pos-
sible 50,841 participant-days (269 participants x 189
intervention days) in the study. Less than 2% (n=516) of
the daily step values were below 500 steps/day, while
less than 1% (n=255) were above 30,000 steps/day. On
average, participants reported steps/day for 104 (SD =
70 days) of the 189 intervention days, with 41% of parti-
cipants recording daily step values for at least 75% of the
intervention days.
Table 2 contains descriptive statistics for the indicators
of pedometer-determined steps/day for all three datasets.
For the full dataset, intervention mean and median
steps/day were 7,268 and 6,918, respectively. On average,
40% and 26% of the participants’ reported daily steps
met at least 7,500 or 10,000 steps/day, respectively.
Table 1 Baseline demographic and clinical characteristics
of HUB City Steps participants (N=269), Mississippi, 2010
(Continued)
Low density lipoprotein (mg/dL) 100 35.4
Triglycerides (mg/dL) 131 79.8
Glucose (mg/dL) 104 37.4
6-minute walk test (distance = m) 440 68.7
SD, standard deviation
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25% of the participants fell into each of the limited, low
active, and somewhat active step-defined physical activ-
ity categories. For change in intervention indicators, the
mean and median increases in steps/day were 2,013 andTable 2 Descriptive statistics for steps/day indicators of HUB
Mean
Full dataset (n=27,903 individual steps/day)
Mean steps/day 7268
Met 7,500 steps/daya 40.1
Met 10,000 steps/daya 26.3
6-category SD-PA (n, %)
Basal (<2,500 steps) 11
Limited (2,500-4,999 steps) 61
Low active (5,000-7,499 steps) 69
Somewhat active (7,500-9,999 steps) 54
Active (10,000-12,499 steps) 29
Highly active (≥12,500 steps) 15
Change in mean steps/dayb 2013
Change in median steps/dayb 2102
Change in 6-category SD-PAb 0.7
Change in 4-category SD-PAb 0.5
Truncated dataset (n=27,903 individual steps/day)
Mean steps/day 7221
Met 7,500 steps/daya 40.1
Met 10,000 steps/daya 26.3
Change in mean steps/dayb 1950
Change in median steps/dayb 2093
Change in 6-category SD-PAb 0.7
Change in 4-category SD-PAb 0.5
Excluded dataset (n=27,132 individual steps/day)
Mean steps/day 7279
Met 7,500 steps/daya 40.8
Met 10,000 steps/daya 26.6
Change in mean steps/dayb 1855
Change in median steps/dayb 1954
Change in 6-category SD-PAb 0.7
Change in 4-category SD-PAb 0.6
SD, standard deviation; Min, minimum; Max, maximum; SD-PA, step-defined physica
a Percentage of values which met at least 7,500 or 10,000 steps/day.
b Change between intervention weeks 1 and 2 and remaining intervention weeks (
Positive change indicates an increase during intervention.2,102 steps, respectively, while increases in the six- and
four-category step-defined physical activity indicators
were 0.7 and 0.5 categories, respectively.Anthropometric and clinical parameter associations
Results for the three pedometer datasets (full, truncated,
and excluded) were similar and yielded few meaningful
differences in interpretation of the findings. Hence, only
results for the full dataset will be reported here. Bivariate
associations between steps/day indicators and outcome
changes, including anthropometric (waist circumference,
BMI, %BF, fat mass, and lean mass), lipid profiles (total
cholesterol, HDL, LDL, and triglycerides), glucose, and
blood pressure (SBP and DBP) are presented in Table 3.City Steps participants, Mississippi, 2010
Median SD Min Max
6918 3984 511 30628
39.0 29.5 0.0 98.5







1205 3257 −7640 17819
1386 3668 −8656 23730
0.0 1.10 −3 4
0.0 0.96 −3 3
6914 3721 743 24575
39.0 29.5 0.0 98.5
16.9 27.2 0.0 97.0
1205 3001 −7427 13481
1386 3596 −8464 21422
0.0 1.09 −3 4
0.0 0.95 −3 3
6972 3417 1276 20637
40.1 29.5 0.0 98.5
17.3 27.3 0.0 97.0
1257 2710 −5931 13237
1344 3084 −5040 15906
1.0 1.02 −2 4
0.0 0.92 −2 3
l activity.
3–27).
Table 3 Bivariate associations between outcome changesa and steps/day indicators using full dataset: HUB City Steps,
Mississippi, 2010
n r P r P
Mean steps/day Median steps/day
Waist Circumference 178 −0.08 NS Waist Circumference −0.10 NS
Body mass index 179 −0.12 NS Body mass index −0.12 NS
% Body fat 177 −0.15 0.0469 % Body fat −0.15 0.0473
Fat mass 177 −0.08 NS Fat mass −0.08 NS
Lean body mass 177 −0.05 NS Lean body mass −0.05 NS
Total cholesterol 179 −0.13 0.0825 Total cholesterol −0.15 0.0472
HDL 177 0.01 NS HDL 0.02 NS
LDL 153 −0.09 NS LDL −0.09 NS
Triglycerides 179 −0.12 NS Triglycerides −0.11 NS
Glucose 179 −0.11 NS Glucose −0.11 NS
SBP 179 0.00 NS SBP 0.01 NS
DBP 179 0.00 NS DBP 0.00 NS
Met 7,500 steps/dayb Met 10,000 steps/dayb
Waist Circumference 178 −0.06 NS Waist Circumference −0.05 NS
Body mass index 179 −0.05 NS Body mass index −0.13 0.0940
% Body fat 177 −0.10 NS % Body fat −0.15 0.0433
Fat mass 177 −0.03 NS Fat mass −0.11 NS
Lean body mass 177 −0.03 NS Lean body mass −0.04 NS
Total cholesterol 179 −0.16 0.0317 Total cholesterol −0.14 0.0638
HDL 177 −0.01 NS HDL −0.01 NS
LDL 153 −0.04 NS LDL 0.00 NS
Triglycerides 179 −0.15 0.0472 Triglycerides −0.13 0.0741
Glucose 179 −0.13 0.0862 Glucose −0.09 NS
SBP 179 0.01 NS SBP 0.03 NS
DBP 179 −0.02 NS DBP −0.01 NS
Change in mean steps/dayc Change in median steps/dayc
Waist Circumference 165 −0.14 0.0812 Waist Circumference −0.16 0.0395
Body mass index 166 −0.28 0.0003 Body mass index −0.27 0.0005
% Body fat 164 −0.26 0.0008 % Body fat −0.24 0.0020
Fat mass 164 −0.23 0.0027 Fat mass −0.21 0.0068
Lean body mass 164 −0.05 NS Lean body mass −0.06 NS
Total cholesterol 166 −0.10 NS Total cholesterol −0.13 NS
HDL 164 0.05 NS HDL 0.08 NS
LDL 141 −0.10 NS LDL −0.12 NS
Triglycerides 166 −0.04 NS Triglycerides −0.07 NS
Glucose 166 −0.08 NS Glucose −0.07 NS
SBP 166 0.03 NS SBP 0.03 NS
DBP 166 −0.01 NS DBP 0.01 NS
Change in 6-category SD-PAc Change in 4-category SD-PAc
Waist Circumference 165 −0.10 NS Waist Circumference −0.11 NS
Body mass index 166 −0.22 0.0044 Body mass index −0.20 0.0101
% Body fat 164 −0.26 0.0008 % Body fat −0.22 0.0052
Fat mass 164 −0.26 0.0006 Fat mass −0.23 0.0032
Lean body mass 164 0.06 NS Lean body mass 0.05 NS
Total cholesterol 166 −0.10 NS Total cholesterol −0.08 NS
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Table 3 Bivariate associations between outcome changesa and steps/day indicators using full dataset: HUB City Steps,
Mississippi, 2010 (Continued)
HDL 164 0.05 NS HDL 0.07 NS
LDL 141 −0.07 NS LDL −0.02 NS
Triglycerides 166 −0.03 NS Triglycerides −0.06 NS
Glucose 166 −0.06 NS Glucose −0.05 NS
SBP 166 0.08 NS SBP 0.05 NS
DBP 166 0.03 NS DBP 0.01 NS
r, Pearson's correlation coefficient; SD-PA, step-defined physical activity; HDL, high density.
lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure.
a Change = baseline subtracted from six-month follow-up.
b Percentage of values which met at least 7,500 or 10,000 steps/day.
c Change between intervention weeks 1 and 2 and remaining intervention weeks (3–27).
Positive change indicates an increase during intervention.
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correlation was observed with %BF (r = −0.15), while a
trending (0.05 < P < 0.10) negative correlation was
observed with total cholesterol (r = −0.13). Similar
results were seen with intervention median steps/day in
which correlations with %BF and total cholesterol were
both significant (both r = −0.15). For the proportion of
reported values meeting at least 7,500 steps/day, signifi-
cant negative correlations were apparent with changes in
total cholesterol and triglycerides, while the negative
correlation with change in glucose was trending towards
significance (r = −0.16, -0.15, and −0.13, respectively).
For the proportion of reported values meeting at
least10,000 steps/day, a significant negative correlation
was apparent with %BF(r = −0.15); negative correlations
with BMI, total cholesterol, and triglycerides were
trending towards significance (−0.14 ≤ r ≤ −0.13). No
discernible trends were observed among the four- and
six-categories of step-defined physical activity indicators
and changes in any of the anthropometric or clinical
outcome variables (data not shown). For change in inter-
vention mean and median steps/day, significant negative
correlations were observed with changes in waist cir-
cumference (trending for mean steps/day), BMI, %BF,
and fat mass (−0.28 ≤ r ≤ −0.14). Similarly, for changes
in intervention four-and six-category classifications,
significant negative correlations were observed with
changes in BMI, %BF, and fat mass (−0.26 ≤ r ≤ −0.20).Multivariate linear regression models
A comparison of the multivariable linear regression ana-
lysis results for the three datasets is presented in Table 4.
In the presence of significant covariates, various descrip-
tive indicators of steps/day were significant predictors of
changes in anthropometric (but not clinical) outcomes.
Using %BF as an example, a 1,000 steps/day increase in
intervention mean and similar change in intervention
mean steps/day resulted in 0.2% decreases in %BF.
An increase of 1% in the number of reported days(approximately 2) meeting at least 10,000 steps/day resulted
in a 2% decrease in %BF, while a one category change in
the six-category step-defined physical activity classification
resulted in a 0.6% decrease in %BF. Decreases in anthropo-
metric outcomes were significantly larger for males as com-
pared to females. Age and fitness were significant negative
predictors, while BMI and income were significant positive
predictors of changes in various anthropometric outcome
models. The only significant predictors in the clinical out-
come models were fitness (negative for triglycerides and
glucose) and diagnosis of relevant condition (positive for
glucose). For all of the anthropometric and clinical models,
their respective baseline outcome values were significant
negative predictors of changes. Marital status, education,
smoking status, and compliance with recording steps/day
were not significant in any of the models.
In general, meaningful differences in the magnitude of
model effects for the descriptive indicators of steps/day
on changes in the anthropometric outcomes were not
present when using the full, truncated, or excluded data-
sets. However, restricting steps/day indicators to include
only plausible values may result in stronger predictive
ability of intervention mean and median steps/day for
changes in waist circumference, and changes in inter-
vention classification of step-defined physical activity for
changes in %BF and fat mass. Coefficients of larger mag-
nitude were mostly obtained using the excluded as com-
pared to the full and truncated datasets. For example,
a 1,000 steps/day increase in change in intervention
mean steps/day resulted in 0.33, 0.38, and 0.45 cm
decreases in waist circumference using the full, trun-
cated, and excluded datasets, respectively. Differences in
the model coefficient magnitudes ranged from −0.05 to
0.0 between the full and truncated datasets, -0.17 to 0.01
between the full and excluded datasets, and −0.15 to
0.01 between the truncated and excluded datasets.
Discussion
The primary objective of this secondary analysis of the
HUB City Steps data was to evaluate the utility of




Outcome Steps/Day Indicator βc P βc P βc P Covariatesd,e
Waist circumference Change in mean steps/dayf −0.33 0.0476 −0.38 0.0419 −0.45 0.0296 BMI, BV
Change in median steps/dayf −0.33 0.0269 −0.33 0.0283 −0.45 0.0123 BMI, BV
Body mass index Met 10,000 steps/dayg −1.05 0.0017 −1.05 0.0017 −1.04 0.0017 Age, BV
Change in mean steps/dayf −0.11 <0.0001 −0.12 <0.0001 −0.13 <0.0001 Age, BV
Change in median steps/dayf −0.10 <0.0001 −0.10 <0.0001 −0.12 <0.0001 Age, BV
Change in 6-category SD-PAf −0.27 0.0009 −0.28 0.0006 −0.34 0.0001 Age, BV
Change in 4-category SD-PAf −0.29 0.0020 −0.29 0.0018 −0.34 0.0005 Age, BV
% Body fat Mean steps/day −0.15 0.0004 −0.16 0.0006 −0.17 0.0078 Age, sex, BV
Median steps/day −0.14 0.0006 −0.14 0.0007 −0.15 0.0084 Age, sex, BV
Met 10,000 steps/dayg −2.23 0.0007 −2.23 0.0007 −2.25 0.0006 Age, sex, BV
Change in mean steps/dayf −0.21 0.0001 −0.22 0.0002 −0.23 0.0004 Age, sex, fitness, BV
Change in median steps/dayf −0.15 0.0016 −0.17 0.0005 −0.20 0.0006 Age, sex, fitness, BV
Change in 6-category SD-PAf −0.56 0.0005 −0.57 0.0004 −0.64 0.0002 Age, sex, fitness, BV
Change in 4-category SD-PAf −0.53 0.0036 −0.55 0.0029 −0.70 0.0007 Age, sex, income, fitness, BV
Fat mass Change in mean steps/dayf −0.29 <0.0001 −0.32 <0.0001 −0.35 <0.0001 Age, sex, BV
Change in median steps/dayf −0.25 <0.0001 −0.25 0.0001 −0.30 <0.0001 Age, sex, BV
Change in 6-category SD-PAf −0.88 <0.0001 −0.90 <0.0001 −1.02 <0.0001 Age, sex, BV
Change in 4-category SD-PAf −0.90 0.0002 −0.91 0.0001 −1.05 <0.0001 Age, sex, BV
Total cholesterol Mean steps/day NS NS NS BV
Median steps/day NS NS NS BV
Met 7,500 steps/dayg NS NS NS BV
Met 10,000 steps/dayg NS NS NS BV
Triglycerides Met 7,500 steps/dayg NS NS NS Fitness, BV
Met 10,000 steps/dayg NS NS NS Fitness, BV
Glucose Met 7,500 steps/dayg NS NS NS DX, fitness, BV
BV, baseline value of corresponding outcome variable; SD-PA, step-defined physical activity; NS, not significant at the 0.05 level; DX = diagnosis for relevant
condition (high cholesterol, high blood glucose).
a Change = baseline subtracted from six-month follow-up.
b Full included all steps/day values; truncated included all values with those < 500 recorded as 500 steps/day and those > 30,000 recorded as 30,000 steps/day;
excluded included only values between 500 and 30,000 steps/day.
c Continuous variable coefficient per 1,000 steps.
d Included age (years), sex, marital status (married or not married), education (less than high school, high school/GED, some college/technical), income
(continuous as 12 categories), current smoker, BMI, DX, fitness (baseline value for 6-minute walk test), compliance (proportion of daily step logs completed), and
baseline outcome value.
e For all significant outcome models: age, sex (decrease larger for males), fitness, and baseline outcome values had negative associations; income and baseline
BMI values had positive associations.
f Change between intervention weeks 1 and 2 and remaining intervention weeks (3–27). Positive change indicates an increase during intervention
g Percentage of values which met at least 7,500 or 10,000 steps/day.
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day for predicting changes in anthropometric and clin-
ical outcomes. Our preliminary findings had established
overall significant intervention effects on SBP, DBP, and
waist circumference, but not for any other anthropo-
metric or clinical parameter [34]. However, steps/day
indicators were not included in these prior analyses.
Importantly, this current paper establishes that several
steps/day indicators are useful for predicting changesin anthropometric outcomes. For the intervention (com-
puted over the entire intervention period) indicators,
mean and median steps/day were significant predictors
of change in the %BF models, while the proportion of
recorded days meeting at least 10,000 steps/day was a
significant predictor of change in the BMI and %BF
models. For the change (between first two weeks and
remaining intervention weeks) in intervention indica-
tors, changes in mean and median steps/day were
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thropometric outcomes (waist circumference, BMI, %BF,
and fat mass), while changes in the four- or six-category
step-defined physical activity classifications were signifi-
cant predictors of changes for BMI, %BF, and fat mass.
In all cases, increasing steps/day indicator values were
predictive of decreasing anthropometric outcome values.
Similar to our results, a trending correlation between in-
creasing change in intervention steps/day and decreasing
BMI was observed in a separate six-month community
walking intervention conducted in southern African
American adults [35]. Likewise, an increase in steps/day
was significantly correlated with a decrease in visceral
adipose tissue in a walking intervention conducted in
obese Japanese men [36]. Further, using categorical
increases in steps/day, significant associations were
observed with decreases in weight, BMI, hip circumfer-
ence, total fat mass, %BF, and intra-abdominal fat in a
randomized, controlled clinical exercise trial conducted
in both men and women [37]. Differing from our results,
the significant decrease in BMI reported in a 2007 meta-
analysis was not significantly associated with changes
in steps/day [25]. The lack of significant associations
between changes in steps/day and changes in anthropo-
metric outcomes in the meta-analysis may be partly due
to the gross (study) level determination of these associa-
tions. That is, direct associations were not computed on
an individual participant basis within the studies, but
on a gross level as part of the meta-analytic process,
effectively reducing the sample size and potentially dilut-
ing any effects which may have been present at the indi-
vidual level.
In contrast to the anthropometric outcomes, none of
the steps/day indicators were useful for predicting
changes in the clinical outcomes (lipids, blood pressure,
and glucose) in the presence of other covariates. Simi-
larly, significant associations between changes in steps/
day and changes in LDL and glucose were not found in
the meta-analysis [25]. However, while the authors of
the meta-analysis did report that intervention partici-
pants significantly decreased both their SBP and DBP,
the direct association between change in steps/day and
change in blood pressure was only trending towards sig-
nificance (P = 0.08) [25]. In contrast, decreasing trigly-
ceride levels were significantly correlated with increasing
steps/day (changes calculated between months one and
six) in the separate six-month community walking inter-
vention conducted in southern African American adults
[35]. Trending correlations between increasing steps/day
and decreasing DBP and increasing HDL were also
found [35]. It may be that the lack of association be-
tween steps/day indicators and clinical outcome changes
in the current study is at least partly due to the partici-
pants’ fairly normal baseline clinical values. Furtherresearch is warranted to determine if steps/day indica-
tors are useful predictors of intervention-induced
changes in related clinical outcomes using more health
disparate populations, such as individuals with hyperten-
sion, diabetes, or cardiovascular disease.
A secondary objective of this study was to evaluate
whether treating steps/day data for implausible values
affected the ability of these data to predict intervention-
induced changes in clinical and anthropometric out-
comes. Since none of the pedometer-determined steps/
day indicators were significant in the clinical outcome
models, only the results for the anthropometric out-
comes will be discussed. We found that treating the
steps/day data for implausible values did not appear to
affect the magnitude of the model coefficients for pre-
dicting intervention-induced anthropometric changes in
a meaningful manner. However, with the exception of
the BMI model using the proportion of values meeting
at least 10,000 steps/day, coefficients of greater magni-
tude were obtained using the excluded compared to the
full and truncated datasets. The largest differences in
model coefficients among the three datasets were
observed for the intervention mean and median steps/
day predicting changes in waist circumference, and
changes in intervention classification of step-defined
physical activity categories predicting changes in %BF
and fat mass. It is not clear why these differences were
found and no supporting data could be identified in the
literature. It is possible that direct measures of body fat,
including central adiposity, are more sensitive to im-
plausible steps/day values than are other anthropometric
measures such as BMI. Excluding implausible values
reduces the variability present in the extremities of
steps/day distributions which may strengthen relation-
ships between steps/day indicators and some anthropo-
metric outcome changes. Exploratory analyses using
pedometer data from a subset of participants in this
study who reported at least one implausible steps/day
value suggest this may be true as differences between
model coefficients using full and excluded datasets were
magnified for waist circumference, %BF, and fat mass
(but not for BMI) in this subset compared to the full set
of participants (data not shown).
Study limitations and strengths
The main limitations of the present study are the self-
report nature of the steps/day data and the lack of infor-
mation on the intensity or speed of participant walking.
Despite accumulating steps, it is feasible that the inten-
sity and/or duration of walking bouts were not sufficient
to achieve health benefits or changes in anthropometric
or clinical outcomes. Evidence suggests that additional
health benefits are possible from participation in higher
intensity and/or longer duration physical activity [38].
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steps/day data collected as part of the original study
design, a limitation that most directly impacts this sec-
ondary analysis. Nevertheless, due to the continuous
recording implemented during the intervention, we were
able to describe change from the first two weeks through
the remaining intervention weeks. The magnitude of
change apparent from this analysis is similar to increases
reported in three meta-analyses conducted on pedometer-
based intervention studies which did include baseline
assessments [16,25,39]. Further, it is possible that some of
the increase in steps/day observed in this study may have
been partly due to seasonal changes [40] since data collec-
tion began in the winter and ended in the summer. The
non-fasted status for the blood lipids and glucose mea-
sures is also a limitation, particularly for triglycerides [41].
Finally, we recognize that anthropometric and clinical out-
come changes could have been attributed to intervention
components other than physical activity, such as dietary
changes and motivational interviewing. However, explor-
ation of these components in conjunction with the exten-
sive analysis of the pedometer-determined steps/day is
beyond the scope of this paper and should be addressed in
future research. Despite these limitations, the strengths of
this secondary analysis are derived from the original study
design that included the community-based (i.e. “real life”)
nature of the study, the option of either paper or web-
based recording of pedometer logs (as preferred by the
participant), and the collection of steps/day for the entire
length of the intervention (vs. the more typical limited
number of days at the beginning and end of the study).
Conclusions
These results suggest that several descriptive indicators
of steps/day may be useful for predicting changes in an-
thropometric outcomes in a southern US, African
American, adult population. While both intervention
(computed based on data collected over the entire inter-
vention period) and change (from first two weeks to re-
mainder of intervention weeks) in intervention steps/day
indicators were significant predictors of changes in an-
thropometric measures, only the change in intervention
steps/day indicators were useful for all four anthropo-
metric outcomes (waist circumference, BMI, %BF, and
fat mass). In general, meaningful differences in the mag-
nitude of model effects for the steps/day indicators on
changes in the anthropometric outcomes were not
present when implausible steps/day were either trun-
cated or excluded compared to the model coefficients
obtained with the full set of values. These results suggest
that manipulating steps/day data to address implausible
values has little overall effect on the ability to predict
intervention-induced anthropometric changes. Further
research is warranted as these results indicate thatthe approach used in the handling and analysis of
pedometer-determined steps/day data may depend upon
the study outcomes measured. Until then, we suggest
that change in mean steps/day may be the most useful
descriptive indicator for predicting changes in anthropo-
metric outcomes due to its association with a number
of anthropometric measures as well as its intuitively
acceptable interpretation.
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